Octapharma Pharmazeutika Produktionsges.m.b.H - search results

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

albunorm octapharma 5% solution for i/v infusion

octapharma pharmazeutika produktionsges. m.b.h. - albumin human - solution for i/v infusion - 50mg/ml

albunorm octapharma 20% solution for i/v infusion

octapharma pharmazeutika produktionsges. m.b.h. - albumin human - solution for i/v infusion - 200mg/ml

albunorm octapharma 20% solution for i/v infusion

octapharma pharmazeutika produktionsges. m.b.h. - albumin human - solution for i/v infusion - 200mg/ml

albunorm octapharma 5% solution for i/v infusion

octapharma pharmazeutika produktionsges. m.b.h. - albumin human - solution for i/v infusion - 50mg/ml

United States - English - NLM (National Library of Medicine)

albumin (human)- albumin human solution

octapharma pharmazeutika produktionsgesellschaft m.b.h. - albumin (human) (unii: zif514rvzr) (albumin (human) - unii:zif514rvzr) - albumin (human) 50 g in 1000 ml - albumin (human) 5% is indicated in the emergency treatment of hypovolemia with or without shock. its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. it is most effective in patients who are well hydrated. when blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [1, 2] albumin (human) 5% should be used when hydration is not adequate. when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] for subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, albumin (human) 5% infusions may be indicated.[ 3 ] when albumin deficit is the result of excessive protein loss, the effect of administration of albumin (human) 5% will be temporary unless the underlying disorder is reversed. albumin (human) 5% may be used to maintain cardiovascular fu

United States - English - NLM (National Library of Medicine)

albumin (human)- albumin human solution

octapharma pharmazeutika produktionsgesellschaft m.b.h. - albumin (human) (unii: zif514rvzr) (albumin (human) - unii:zif514rvzr) - albumin (human) 200 g in 1000 ml - albumin (human) 20% is indicated in the emergency treatment of hypovolemia with or without shock. its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. it is most effective in patients who are well hydrated. when blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [1, 2] when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] for subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, albumin (human) 20% infusions may be indicated. [ 3 ] when albumin deficit is the result of excessive protein loss, the effect of administration of albumin (human) 20% will be temporary unless the underlying disorder is reversed. albumin (human) 20% may be used to maintain cardiovascular function following the removal of large volumes of ascitic flui

United States - English - NLM (National Library of Medicine)

albumin (human)- albumin human solution

octapharma pharmazeutika produktionsgesellschaft m.b.h. - albumin (human) (unii: zif514rvzr) (albumin (human) - unii:zif514rvzr) - albumin (human) 250 g in 1000 ml - albumin (human) 25% is indicated in the emergency treatment of hypovolemia with or without shock. its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. it is most effective in patients who are well hydrated. when blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [1, 2] when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] for subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, albumin (human) 25% infusions may be indicated. [ 3 ] when albumin deficit is the result of excessive protein loss, the effect of administration of albumin (human) 25% will be temporary unless the underlying disorder is reversed. albumin (human) 25% may be used to maintain cardiovascular function following the removal of large volumes of ascitic flui

octanate 250iu

octapharma pharmazeutika produktionsges. m.b.h. - human blood coagulation factor viii - powder lyophilized for solution for injection - 250iu/vial

octanate 500iu

octapharma pharmazeutika produktionsges. m.b.h. - human blood coagulation factor viii - powder lyophilized for solution for injection - 500iu/vial

octanate 1000iu

octapharma pharmazeutika produktionsges. m.b.h. - human blood coagulation factor viii - powder lyophilized for solution for injection - 1000iu/vial